Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma

Cancer

Volumn 83, Issue 1, 1998, Pages 158-165

  Gisbertz, Ingrid A M ^a   Schouten, Harry C ^a   Bot, Fredrik J ^b   Arends, Jan Willem ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Bcl 2; Classification; Intestinal lymphoma; Mucosa associated lymphoid tissue; Proliferation; Terminal deoxynucleotidyl transferase mediated digoxigenin dUTP nick end labeling (TUNEL)

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; TURNOVER TIME;

APOPTOSIS; CELL DIVISION; GENES, P53; HUMANS; INTESTINAL NEOPLASMS; LYMPHOMA, NON-HODGKIN; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032126466     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<158::AID-CNCR21>3.0.CO;2-V     Document Type: Article

References (38)

1. Dragosics B, Bauer P, Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas: a retrospective clinicopathological study of 150 cases. Cancer 1985;55:1060-73.
2. Weingrad DN, Decosse JJ, Sherlock P, Straus D, Lieberman PH, Filippa DA. Primary gastrointestinal lymphoma: a 30-year review. Cancer 1982;49:1258-65.
3. Weiss NS, Yang CP. Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst 1987;78:653-6.
4. DiSario IA, Burt RW, Kendrick ML, McWhorter WP. Colorectal cancers of rare histologic types compared with adenocarcinomas. Dis Colon Rectum 1994;37:1277-80.
5. Zighelboim J, Larson MV. Primary colonic lymphoma: clinical presentation, histopathological features, and outcome with combination chemotherapy. J Clin Gastroenterol 1994; 18:291-7.
6. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992;80:8-20.
7. Nalesnik MA, Jaffe R, Starzl TE. The pathology ot posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
8. Du M, Singh N, Husseuin A, Isaacson PG, Pan L. Positive correlation between apoptotic and proliferate indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT). J Pathol 1996;178:379-84.
9. Gisbertz IAM, Schouten HC, Bot FJ, Arends J-W. Proliferation and apoptosis in primary gastric B-cell non-Hodgkin's lymphoma. Histopathology 1997;30:152-9.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
11. Wijsman JH, Jonker RR, Keijzer R, Van DeVelde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
12. L and bcl-2 repress a common pathway of cell death. J Exp Med 1995;182:821-8.
13. Hockenbery DM. The bcl-2 gene and apoptosis. Semin Immunol 1992;4:413-20.
14. Mazel S, Burtrum D, Petrie HT. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 1996;183:2219-26.
15. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995;92:8493-7.
16. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J 1990;9:1595-1602.
17. Newcomb EW. p53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk Lymphoma 1995;17:211-21.
18. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990;55:133-70.
19. Rohatiner A, D'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.
20. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. Cancer 1983;52:1410-6.
21. Isaacson PG. Lymphomas of mucosa-associated lymphoid tissue (MALT). Histopathology 1990;16:617-9.
22. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987;11:445-62.
23. deJong D, Boot H, Van Heerde P, Hart GAM, Taal BG. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997;112: 1466-74.
24. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
25. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - revisited! J Pathol 1994;172:1-4.
26. Leoncini L, Del Vecchio MT, Megha T, Barbini D, Galieni P, Pileri S, et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993;142:755-63.
27. Marx J. Cell death studies yield cancer clues. Science 1993; 259:760-1.
28. Rivas C, Echezarreta G, Garcia R, Santos M, Santon A, Robledo M, et al. A multiparametric study of malignant lymphoma of mucosa-associated lymphoid tissue. Leuk Lymphoma 1992;8:87-96.
29. Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP, et al. The assessment of proliferating nuclear cell antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991;19:21-7.
30. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994;73:2013-26.
31. Sedivy R. The potential role of apoptosis (programmed cell death) in a chaotic determined carcinogenesis. Med Hypotheses 1996;46:455-7.
32. Wyllie AH, Kerr JRR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251.
33. Spina D, Leoncini L, Del Vecchio MT, Megha T, Minacci C, Poggi SA, et al. Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol 1995;177:335-41.
34. Kojima M, Nakamura S, Kurabayashi Y, Shimizu K, Mosomura Y, Ohno Y, et al. Primary malignant lymphoma of the intestine: clinicopathologic and immunohistochemical studies of 39 cases. Pathol Int 1995;45:123-30.
35. Radasziewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992; 102:1628-38.
36. Martinez-Delgado B, Robledo M, Arranz E, Infantes F, Echezarreta G, Marcos B, et al. Correlation between mutations in p53 gene and protein expression in human lymphomas. Am J Hematol 1997;55:1-8.
37. Bonsing BA, Corver WE, Gorsira MCB, Van Vliet M, Oud PS, Cornelisse CJ, et al. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning, microscopy and flow cytometry. Cytometry 1997;28:11-24.
38. Murray A, Cuevas EC, Jones DB, Wright DH. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995;146: 509-19.